Suzano Completes $1.3B Acquisition of 51% Stake in Kimberly-Clark JV, Forms New Tissue Business 'Arbex'

summarizeSummary

Suzano S.A. has finalized its $1.3 billion acquisition of a 51% controlling stake in a joint venture with Kimberly-Clark, establishing a new tissue business named Arbex and expanding its strategic footprint.

check_boxKey Events · M&A and Partnerships · SUZ

• Joint Venture Acquisition Closed

  Suzano S.A. completed the acquisition of a 51% equity interest in FamPro Tissue Holdings B.V. (now Arbex) from Kimberly-Clark Corporation, following prior antitrust approvals.

• Significant Financial Commitment

  The transaction involved a payment of USD 1.3 billion by Suzano, with the joint venture also carrying approximately USD 1.0 billion in net debt from financing.

• Strategic Entry into Tissue Business

  This acquisition aligns with Suzano's long-term strategy for value-accretive growth, marking its entry into the tissue business by leveraging its competitive strengths in pulp.

• New Governance Structure Established

  A new Board of Directors and C-level management structure have been defined for Arbex, including key executives from both Suzano and Kimberly-Clark.

auto_awesomeAnalysis · SUZ · Manufacturing

Suzano S.A. has finalized a significant strategic move by completing the acquisition of a 51% controlling interest in a joint venture with Kimberly-Clark, now named Arbex. This transaction, valued at $1.3 billion from Suzano, plus an additional $1.0 billion in net debt for the JV, represents a substantial financial commitment and a major expansion into the tissue business. The successful closing of this deal, following prior antitrust approvals, marks a definitive step in Suzano's long-term growth strategy to leverage its pulp strengths in scalable businesses.